Free Trial

Occudo Quantitative Strategies LP Purchases New Holdings in Red Violet, Inc. (NASDAQ:RDVT)

Red Violet logo with Computer and Technology background

Occudo Quantitative Strategies LP bought a new position in shares of Red Violet, Inc. (NASDAQ:RDVT - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 8,401 shares of the company's stock, valued at approximately $304,000. Occudo Quantitative Strategies LP owned about 0.06% of Red Violet at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the business. JPMorgan Chase & Co. grew its position in shares of Red Violet by 114.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 31,243 shares of the company's stock worth $889,000 after buying an additional 16,661 shares in the last quarter. Barclays PLC grew its position in shares of Red Violet by 240.7% during the 3rd quarter. Barclays PLC now owns 18,502 shares of the company's stock worth $526,000 after buying an additional 13,072 shares in the last quarter. SG Americas Securities LLC grew its position in shares of Red Violet by 14.3% during the 4th quarter. SG Americas Securities LLC now owns 7,990 shares of the company's stock worth $289,000 after buying an additional 998 shares in the last quarter. Hennion & Walsh Asset Management Inc. bought a new position in shares of Red Violet during the 4th quarter worth $232,000. Finally, Ellsworth Advisors LLC bought a new position in shares of Red Violet during the 4th quarter worth $619,000. 63.56% of the stock is currently owned by institutional investors.

Red Violet Stock Up 0.3%

Shares of NASDAQ RDVT traded up $0.17 during mid-day trading on Tuesday, reaching $49.29. 83,338 shares of the company were exchanged, compared to its average volume of 71,633. The stock has a market cap of $687.89 million, a price-to-earnings ratio of 136.92 and a beta of 1.69. Red Violet, Inc. has a 1 year low of $19.76 and a 1 year high of $49.80. The firm has a 50-day moving average of $39.66 and a 200 day moving average of $37.90.

Insiders Place Their Bets

In other news, insider Jeffrey Alan Dell sold 5,000 shares of Red Violet stock in a transaction on Friday, May 9th. The stock was sold at an average price of $46.20, for a total value of $231,000.00. Following the completion of the sale, the insider now directly owns 172,968 shares of the company's stock, valued at approximately $7,991,121.60. The trade was a 2.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Steven D. Rubin sold 10,000 shares of the company's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $38.93, for a total transaction of $389,300.00. Following the sale, the director now directly owns 141,138 shares in the company, valued at approximately $5,494,502.34. The trade was a 6.62% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 25,000 shares of company stock valued at $1,082,400 in the last 90 days. 9.50% of the stock is owned by insiders.

Red Violet Profile

(Free Report)

Red Violet, Inc, a software and services company, specializes in proprietary technologies and applying analytical capabilities to deliver identity intelligence in the United States. It offers idiCORE, an investigative solution used to address various organizational challenges, which include due diligence, risk mitigation, identity authentication, fraud detection and prevention, customer acquisition, and regulatory compliance; and FOREWARN, an app-based solution that provides instant knowledge before face-to-face engagement with a consumer, as well as helps professionals to identify and mitigate risk.

Recommended Stories

Institutional Ownership by Quarter for Red Violet (NASDAQ:RDVT)

Should You Invest $1,000 in Red Violet Right Now?

Before you consider Red Violet, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Red Violet wasn't on the list.

While Red Violet currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines